Pharmaceutical Technology
MAY 17, 2024
With patients taking control over health, experts discuss how different players in the healthcare system are responding to the shifting relationship.
Bio Pharma Dive
MAY 17, 2024
Imdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following chemotherapy in treating extensive-stage small cell lung cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 17, 2024
The US Senator took another swipe at the US prices of Novo Nordisk’s blockbuster GLP-1 receptor agonist drugs Ozempic and Wegovy.
Bio Pharma Dive
MAY 17, 2024
The cancer biotech is laying off one-fifth of its staff and scrapping three drugs. Elsewhere, Novartis secured sufficient support for its $3B buyout and Bristol Myers won a new CAR-T approval.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Pharma Times
MAY 17, 2024
Areas include health research across life stages, from paediatrics to health ageing and resilience
Pharmaceutical Technology
MAY 17, 2024
J&J has gained access to several bispecific antibody programmes, including the Phase I-ready asset PX128 for atopic dermatitis and asthma.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
MAY 17, 2024
Erasca has made operational cuts while licensing a molecular glue therapy and a KRAS inhibitor for $22.5m upfront.
pharmaphorum
MAY 17, 2024
Navigating maternal vaccine trials: addressing safety, efficacy, and preterm birth risks. Insights on vaccines for pregnant women and maternal health.
Pharmaceutical Technology
MAY 17, 2024
Galapagos has signed a partnership with Blood Centers of America to expedite decentralised production of CAR-T cell therapies across the US.
pharmaphorum
MAY 17, 2024
Explore sustainable catalysis and its potential to transform chemical reactions in drug discovery. Learn how green chemistry plays a pivotal role in shaping the future of catalysis.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
MAY 17, 2024
Moxifloxacin is under clinical development by Laboratorios Sophia and currently in Phase I for Bacterial Conjunctivitis.
pharmaphorum
MAY 17, 2024
Brainomix gets FDA approval for e-Lung, an AI tool that assists in the diagnosis and assessment of patients with interstitial lung diseases (ILDs) from medical images.
Pharmaceutical Technology
MAY 17, 2024
CinDome Pharma has secured $40m in a Series B financing extension round to develop deudomperidone for chronic gastroparesis.
pharmaphorum
MAY 17, 2024
Amgen gets FDA approval for Imdelltra as a treatment for small cell lung cancer, becoming the first DLL3-targeted drug and the company's second BiTE therapy.
Pharmaceutical Technology
MAY 17, 2024
The US FDA has granted breakthrough therapy designation (BTD) for Nuvalent’s NVL-655 for the treatment of non-small cell lung cancer.
Fierce Pharma
MAY 17, 2024
After Moderna last year suffered a loss in its heated patent fight against Pfizer and BioNTech, the mRNA drugmaker can now celebrate a win. | The win comes after a prior decision from the European Patent Office that invalidated Moderna's other asserted patent.
BioPharma Reporter
MAY 17, 2024
Endeavor BioMedicines, a clinical-stage biotech company, has announced promising phase 2a trial results for its lead investigational candidate, ENV-101.
pharmaphorum
MAY 17, 2024
Bernie Sanders says high prices being charged for new obesity therapies like Novo Nordisk’s Wegovy could end up bankrupting US healthcare systems
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Commerce
MAY 17, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
pharmaphorum
MAY 17, 2024
Johnson & Johnson has agreed a $850m deal to acquire Proteologix that will give it a pair of early-stage bispecific antibodies for atopic dermatitis and asthma.
Cloudbyz
MAY 17, 2024
The European Parliament recently passed the EU’s new AI Act , which is now awaiting final approval. This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation.
Pharmaceutical Technology
MAY 17, 2024
PF-08046040 is under clinical development by Pfizer and currently in Phase I for Myelodysplastic Syndrome.
Fierce Pharma
MAY 17, 2024
Following a controversy over Covis’ preterm birth drug Makena in the U.S. last year, the European Medicines Agency (EMA) is cracking down on hydroxyprogesterone caproate therapies across the pond. | A committee of the European Medicines Agency on Friday called for the withdrawal of preterm birth drugs containing 17-hydroxyprogesterone caproate (17-OHPC), citing safety and efficacy concerns.
Pharmaceutical Technology
MAY 17, 2024
Gene Therapy for Parkinson’s Disease is under clinical development by Innervate Therapeutics and currently in Phase II for Parkinson's Disease.
Fierce Pharma
MAY 17, 2024
Seven months after Amgen’s chief medical officer referred to trial | Seven months after Amgen’s chief medical officer referred to trial results for the company's investigational lung cancer immunotherapy as a “watershed moment,” the FDA has signed off on Imdelltra (tarlatamab) to treat patients with extensive-stage small-cell lung cancer (ES-SCLC).
Pharmaceutical Technology
MAY 17, 2024
MAI-001 is under clinical development by Nanjing Minova Pharmaceutical Technology and currently in Phase I for Depression.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Cloudbyz
MAY 17, 2024
When choosing an Electronic Trial Master File (eTMF) system for your clinical trials, it’s crucial to ensure the system not only meets your organizational needs but also complies with regulatory requirements and enhances operational efficiency. Here is a detailed buyer’s checklist for your reference: File Management Capabilities Drag and Drop Uploads: Check if the system supports drag-and-drop functionality during file uploads to simplify the process Document Favorites and Navigation: The system
Pharmaceutical Technology
MAY 17, 2024
IL13R alpha 2 CAR-T is under clinical development by TCR Cure Biopharma Technology and currently in Phase I for Glioma.
pharmaphorum
MAY 17, 2024
An artificial intelligence-driven WhatsApp messaging platform for scheduling cervical cancer screening appointments is being piloted in London to see if it can improve take-up rates. The pilot of the Asa AI assistant – cleared by the NHS North Central London Integrated Care Board (ICB) – will take place at the Islington GP Federation in London.
Pharmaceutical Technology
MAY 17, 2024
TNT-119 is under clinical development by Eliem Therapeutics and currently in Phase I for Membranous Glomerulonephritis.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
130 
Let's personalize your content